LifeScience Biologics

Illumina Launches Global Health Access Initiative to Boost Pathogen Sequencing in Low- and Middle-Income Countries

 Illumina Inc, a global leader in DNA sequencing and array-based technologies, announced  the launch of the Global Health Access Initiative to su...

 November 14, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

 November 14, 2023 | News

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

 NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world&rs...

 November 10, 2023 | News

Porton Advanced Partners with BioMap to Boost AAV Gene Therapy with AI Models

The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors, and expanding the application of AI models in ...

 November 09, 2023 | News

BioRay Starts Phase I Study for BRY812, Targeted Antibody Drug Conjugate

LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...

 November 08, 2023 | News

Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors

BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China     Biotheus Inc. ("Biotheus"),...

 November 07, 2023 | News

Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy

These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...

 November 06, 2023 | News

Aquinnah Pharmaceuticals Advances Alzheimer's Tauopathy Program

Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...

 October 31, 2023 | News

Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...

 October 31, 2023 | News

Henlius Expands Partnership with Intas to Introduce Serplulimab in Europe and India

Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalt...

 October 30, 2023 | News

Exactech Announces Clearance for Its New 3D-Printed Vantage® Ankle Tibial Implants

The new implants provide orthopaedic surgeons with additional tibial height options for total ankle replacement patients. Both implants are 3D-printed and ...

 October 27, 2023 | News

Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia

  Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...

 October 27, 2023 | News

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium, a leading innovator of fluorescent dyes for life science research, proudly announces the launch of its breakthrough ...

 October 26, 2023 | News

Lonza's Rapid PyroCell® Enhances Rabbit-Free Pyrogen Testing

Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems...

 October 25, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close